Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

News Focus

Lipari Mining (N.LML) Announces Q1-2025 Production and Sales Results (click to learn more)

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News UNITY Biotechnology Inc UBX

Healthcare Biotechnology

UNITY Biotechnology, Inc. is a biotechnology company engaged in researching and developing therapeutics to slow, halt or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. It is targeting specific biological mechanisms... see more

Add To Watchlist

Recent & Breaking News (NDAQ:UBX)

UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference

GlobeNewswire September 20, 2019

UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire August 27, 2019

UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates

GlobeNewswire August 7, 2019

UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee

GlobeNewswire July 30, 2019

UNITY Biotechnology, Inc. To Announce Second Quarter 2019 Financial Results

GlobeNewswire July 30, 2019

UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee

GlobeNewswire June 18, 2019

UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline

GlobeNewswire May 29, 2019

UNITY Biotechnology, Inc. to Present at Upcoming Investor Conferences

GlobeNewswire May 23, 2019

UNITY Biotechnology, Inc. Reports First Quarter 2019 Financial Results

GlobeNewswire May 8, 2019

UNITY Biotechnology, Inc. to Announce First Quarter 2019 Financial Results

GlobeNewswire April 29, 2019

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Program Updates

GlobeNewswire March 6, 2019

UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference

GlobeNewswire March 4, 2019

CORRECTING and REPLACING -- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire February 27, 2019

UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire February 25, 2019

UNITY Biotechnology Expands Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of the Knee

GlobeNewswire January 22, 2019

Ascentage Pharma Announces New License with Unity Biotechnology

PR Newswire January 8, 2019

UNITY Biotechnology Announces Completion of UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye

GlobeNewswire January 3, 2019

UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors

GlobeNewswire December 4, 2018

UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee

GlobeNewswire December 3, 2018

UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence

GlobeNewswire November 13, 2018